|
| 36368129 | Profiling the immune landscape in mucinous ovarian carcinoma. | Gynecol Oncol | 2023 |
| 36368129 | Profiling the immune landscape in mucinous ovarian carcinoma. | Gynecol Oncol | 2023 |
| 36401943 | Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery. | Gynecol Oncol | 2023 |
| 36968229 | Trends of Ovarian Cancer Incidence by Histotype and Race/Ethnicity in the United States 1992-2019. | Cancer Res Commun | 2023 |
| 37339172 | The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas. | Clin Cancer Res | 2023 |
| 37279208 | A comparative study on behavior, awareness and belief about cervical cancer among rural and urban women in Vietnam. | PLOS Glob Public Health | 2023 |
| 36826816 | Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility. | JAMA Netw Open | 2023 |
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 36626383 | COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination. | Cancer Epidemiol Biomarkers Prev | 2023 |
| 37436712 | A framework for assessing interactions for risk stratification models: the example of ovarian cancer. | J Natl Cancer Inst | 2023 |
| 36688720 | Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis. | J Natl Cancer Inst | 2023 |
| 37279208 | A comparative study on behavior, awareness and belief about cervical cancer among rural and urban women in Vietnam. | PLOS Glob Public Health | 2023 |
| 37339172 | The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas. | Clin Cancer Res | 2023 |
| 37436712 | A framework for assessing interactions for risk stratification models: the example of ovarian cancer. | J Natl Cancer Inst | 2023 |
| 36968229 | Trends of Ovarian Cancer Incidence by Histotype and Race/Ethnicity in the United States 1992-2019. | Cancer Res Commun | 2023 |
| 36626383 | COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination. | Cancer Epidemiol Biomarkers Prev | 2023 |
| 36401943 | Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery. | Gynecol Oncol | 2023 |
| 36688720 | Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis. | J Natl Cancer Inst | 2023 |
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 36826816 | Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility. | JAMA Netw Open | 2023 |
| 34110557 | The Association of Prenatal Vitamins and Folic Acid Supplement Intake with Odds of Autism Spectrum Disorder in a High-Risk Sibling Cohort, the Early Autism Risk Longitudinal Investigation (EARLI). | J Autism Dev Disord | 2022 |
| 36182623 | Effects of risk factors for ovarian cancer in women with and without endometriosis. | Fertil Steril | 2022 |
| 35700017 | Proliferation of the Fallopian Tube Fimbriae and Cortical Inclusion Cysts: Effects of the Menstrual Cycle and the Levonorgestrel Intrauterine Contraceptive System. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 36222710 | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes. | Clin Cancer Res | 2022 |
| 36210504 | Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. | J Natl Cancer Inst | 2022 |
| 35867953 | Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia. | J Clin Oncol | 2022 |
| 35414426 | Aging accelerates while multiparity delays tumorigenesis in mouse models of high-grade serous carcinoma. | Gynecol Oncol | 2022 |
| 36456881 | The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer. | Nat Genet | 2022 |
| 34110557 | The Association of Prenatal Vitamins and Folic Acid Supplement Intake with Odds of Autism Spectrum Disorder in a High-Risk Sibling Cohort, the Early Autism Risk Longitudinal Investigation (EARLI). | J Autism Dev Disord | 2022 |
| 35064059 | Reproductive Factors Do Not Influence Survival with Ovarian Cancer. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 34789471 | High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 34782936 | MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. | Virchows Arch | 2022 |
| 34776242 | Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association. | Gynecol Oncol | 2022 |
| 35138400 | Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention. | JAMA Netw Open | 2022 |
| 35700017 | Proliferation of the Fallopian Tube Fimbriae and Cortical Inclusion Cysts: Effects of the Menstrual Cycle and the Levonorgestrel Intrauterine Contraceptive System. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35414426 | Aging accelerates while multiparity delays tumorigenesis in mouse models of high-grade serous carcinoma. | Gynecol Oncol | 2022 |
| 36456881 | The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer. | Nat Genet | 2022 |
| 36182623 | Effects of risk factors for ovarian cancer in women with and without endometriosis. | Fertil Steril | 2022 |
| 36210504 | Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. | J Natl Cancer Inst | 2022 |
| 35867953 | Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia. | J Clin Oncol | 2022 |
| 36222710 | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes. | Clin Cancer Res | 2022 |
| 35064059 | Reproductive Factors Do Not Influence Survival with Ovarian Cancer. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35138400 | Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention. | JAMA Netw Open | 2022 |
| 34789471 | High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 34782936 | MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. | Virchows Arch | 2022 |
| 34776242 | Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association. | Gynecol Oncol | 2022 |
| 32546565 | Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer. | J Med Genet | 2021 |
| 34119716 | Acupressure for Cancer-fatigue in Ovarian Cancer Survivor (AcuOva) Study: A community-based clinical trial study protocol examining the impact of self-acupressure on persistent cancer-related fatigue in ovarian cancer survivors. | Contemp Clin Trials | 2021 |
| 33619020 | Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 34090707 | Cardiovascular medications and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada. | Gynecol Oncol | 2021 |